Filing Details

Accession Number:
0001209191-12-059660
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-28 16:07:55
Reporting Period:
2012-12-26
Filing Date:
2012-12-28
Accepted Time:
2012-12-28 16:07:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509420 D Chandra Lovejoy 3000 Kent Ave, Suite A1-100
West Lafayette IN 47906
Vp Of Regulatory Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-26 107 $2.54 107 No 4 M Direct
Common Stock Disposition 2012-12-26 107 $9.05 0 No 4 S Direct
Common Stock Acquisiton 2012-12-26 2,102 $2.54 2,102 No 4 M Direct
Common Stock Disposition 2012-12-26 2,102 $9.05 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-12-26 107 $0.00 107 $2.54
Common Stock Stock Option (right to buy) Disposition 2012-12-26 2,102 $0.00 2,102 $2.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
322 2019-03-05 No 4 M Direct
1,207 2019-08-13 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a written plan as specified in Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Shares subject to vest monthly over a period of 48 months beginning on March 31, 2009.
  3. Shares subject to vest monthly over a period of 48 months beginning on August 31, 2009.